Gaush Meditech Ltd
Research Gaush Meditech Ltd (2407.HK) on Bullrun: market cap HKD 621.13M, P/E 7.2. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2407.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryMedical Devices
- CurrencyHKD
- Market capHKD 621.13M
- P/E7.2
- Financial periodFY2025
- RevenueCNY 1.38B
- Revenue growth-3.4%
- Net incomeCNY 96.19M
- Free cash flowCNY 110.47M
- Gross margin45.9%
Valuation Snapshot
latest market cap is HKD 621.13M; P/E is 7.2.
Peer valuation comparison
Latest P/E is 7.24x versus a Healthcare sector median of 21.74x (66.7% below).
Latest P/E is 7.24x versus a China median of 16.26x (55.5% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 1.38B | CNY 96.19M | CNY 110.47M | 45.9% | 0.66 | CNY 437.66M | CNY 507.15M | CNY 1.69B |
| FY2024 | CNY 1.43B | CNY 92.39M | CNY 26.57M | 46.4% | 0.63 | CNY 421.44M | CNY 552.24M | CNY 1.58B |
| FY2023 | CNY 1.41B | CNY 173.52M | CNY 203.44M | 49.2% | 1.17 | CNY 618.70M | CNY 664.36M | CNY 1.68B |
| FY2022 | CNY 1.25B | -CNY 349.62M | CNY 186.41M | 49.9% | -3.61 | CNY 721.52M | CNY 756.00M | CNY 1.47B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 621.13M | 7.2 | n/a | 0.3 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.3 HKD.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.3 CNY |
| FY2024 | 1.1 CNY |
About Gaush Meditech Ltd
Gaush Meditech Ltd. engages in research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Gaush Meditech Ltd's market cap?
Gaush Meditech Ltd's market capitalization is HKD 621.13M.
What is Gaush Meditech Ltd's P/E ratio?
Gaush Meditech Ltd's price-to-earnings (P/E) ratio is 7.2.
What does Gaush Meditech Ltd do?
Gaush Meditech Ltd. engages in research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers.